Drug production and precursors — EUDA ongoing activities

The European Union Drugs Agency (EUDA) continues to monitor illicit drug production and precursor chemicals across Europe to improve understanding of how drug markets are evolving. Production within the European Union is primarily focused on synthetic stimulants, including amphetamine, MDMA, methamphetamine, and synthetic cathinones, while production methods are becoming increasingly flexible and adaptive.

The report also highlights the significant environmental and public safety risks associated with illicit drug production. Drug manufacturing can generate large amounts of hazardous chemical waste, contributing to pollution, fire risks, and threats to nearby communities. Criminal networks frequently adapt production methods and substitute precursor chemicals to avoid regulatory controls, creating ongoing challenges for monitoring and enforcement.

Overall, EUDA's work supports policymakers, law enforcement agencies, and public health professionals by providing evidence on drug production trends, precursor trafficking, and emerging risks to inform coordinated responses across Europe.